Tvardi Therapeutics Inc.

NASDAQ: TVRD · Real-Time Price · USD
24.30
0.51 (2.14%)
At close: Aug 15, 2025, 3:59 PM
24.00
-1.23%
After-hours: Aug 15, 2025, 04:10 PM EDT

Tvardi Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
37.9M 22.92M 21.49M 13.45M
Short-Term Investments
n/a n/a 22.25M 153.58M
Long-Term Investments
n/a n/a n/a 70.16M
Other Long-Term Assets
n/a 17K 17K n/a
Receivables
4.5M n/a n/a 1.15M
Inventory
900K n/a n/a 2.58M
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
43.83M 26.16M 44.11M 173.29M
Property-Plant & Equipment
n/a 378K 460K 3.6M
Goodwill & Intangibles
n/a 448K 511K n/a
Total Long-Term Assets
n/a 843K 988K 73.77M
Total Assets
43.83M 27M 45.1M 247.06M
Account Payables
1.43M 1.61M 2.41M 5.63M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a 1.75M
Other Current Liabilities
1.97M 942K 678K 5.28M
Total Current Liabilities
3.97M 3.28M 4.28M 17.62M
Long-Term Debt
44.45M n/a n/a n/a
Other Long-Term Liabilities
n/a 85.5M 85.5M n/a
Total Long-Term Liabilities
44.45M 85.78M 85.87M 1.92M
Total Liabilities
48.42M 89.06M 90.15M 19.53M
Total Debt
44.45M 368K 450K 3.67M
Common Stock
5K 19K 19K 53K
Retained Earnings
-755.61M -62.84M -45.49M -480.76M
Comprehensive Income
n/a n/a -24K -358K
Shareholders Equity
-4.59M -62.06M -45.05M 227.52M
Total Investments
n/a n/a 22.25M 223.74M